Glycerol Phenylbutyrate Oral Liquid shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-09-01 · last update 2026-09-01
Manufacturers: Amgen Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06) | Amgen Inc. | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted 09/01/2026 Updated 09/01/2026 Discontinued 09/01/2026 |
| RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-07) | Amgen Inc. | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted 09/01/2026 Updated 09/01/2026 Discontinued 09/01/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)